Correction to: Immunogenic Yeast-Based Fermentation Product Reduces Allergic Rhinitis-Induced Nasal Congestion: A Randomized, Double-Blind, Placebo-Controlled Trial.


Journal

Advances in therapy
ISSN: 1865-8652
Titre abrégé: Adv Ther
Pays: United States
ID NLM: 8611864

Informations de publication

Date de publication:
Aug 2019
Historique:
pubmed: 4 6 2019
medline: 4 6 2019
entrez: 3 6 2019
Statut: ppublish

Résumé

The article ''Immunogenic Yeast-Based Fermentation Product Reduces Allergic Rhinitis-Induced Nasal Congestion: A Randomized, Double-Blind, Placebo-Controlled Trial'', written by Mark A. Moyad, Larry E. Robinson, Julie M. Kittelsrud, Stuart G. Reeves, Susan E. Weaver, Aireen I. Guzman, Mark E. Bubak was originally published electronically on the publisher's internet portal (currently Springer-Link) on 12 August, 2009.

Identifiants

pubmed: 31154626
doi: 10.1007/s12325-019-00996-5
pii: 10.1007/s12325-019-00996-5
pmc: PMC6822977
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

2191

Commentaires et corrections

Type : ErratumFor

Auteurs

Mark A Moyad (MA)

University of Michigan Medical Center, Department of Urology, Ann Arbor, Michigan, 48109-0330, USA. moyad@umich.edu.

Larry E Robinson (LE)

Vice President, Scientific Affairs, Embria Health Sciences, Ankeny, Iowa, USA.

Julie M Kittelsrud (JM)

Nurse Practitioner, Avera Research Institute, Sioux Falls, South Dakota, USA.

Stuart G Reeves (SG)

Director of Research and Development, Embria Health Sciences, Ankeny, Iowa, USA.

Susan E Weaver (SE)

Nurse Practitioner, Avera Research Institute, Sioux Falls, South Dakota, USA.

Aireen I Guzman (AI)

Statistical Consultant, Avera Research Institute, Sioux Falls, South Dakota, USA.

Mark E Bubak (ME)

Assistant Professor, Allergy, Department of Internal Medicine, USD Sanford School of Medicine, Sioux Falls, South Dakota, USA.

Classifications MeSH